Pharma Pricing Issue
Near-term growth issues and cost pressure could impact Aurobindo Pharma
While valuations are now attractive, product approvals and progress on the injectable guidance are among key long-term term triggers
 "Near-term growth issues and cost pressure could impact Aurobindo Pharma")
Updated On : 03 Jun 2022 | 11:33 PM IST
NPPA vs Pharma makers: Industry body knocks Ananth Kumar's door over notice
NPPA issued show-cause notices to leading drug makers over 'suspected overcharging'
 "NPPA vs Pharma makers: Industry body knocks Ananth Kumar's door over notice")
Updated On : 23 May 2017 | 2:50 AM IST
